C82.55
Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Diffuse follicle center lymphoma is a type of non-Hodgkin lymphoma that originates from the B-lymphocytes in the lymphatic system. The specific code C82.55 refers to cases where this lymphoma affects lymph nodes located in the inguinal (groin) region and the lower limbs. This form of lymphoma often presents as painless swelling of affected lymph nodes and can spread to other parts of the body over time. Understanding its characteristics and how it differs from other lymphomas helps in early diagnosis and management.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal B-cell growth Chronic immune system stimulation or immune deficiency states Environmental exposures to certain chemicals or radiation Infections that may trigger lymphatic cell changes Age-related changes, particularly in older adults
Key Symptoms: Painless swelling or enlargement of lymph nodes in the groin and legs Persistent or worsening fatigue Unexplained weight loss Fever that comes and goes Night sweats Discomfort or pain in the affected areas Possible skin changes or rashes in the regions involved
Diagnostic & Treatment
Diagnosis Path: Diagnosing diffuse follicle center lymphoma in these regions involves a combination of medical evaluations and diagnostic tests, including: - Physical examination focusing on enlarged lymph nodes - Imaging studies such as CT scans or PET scans to assess the extent of spread - Biopsy of affected lymph nodes for microscopic analysis - Blood tests to evaluate overall health and immune function - Laboratory tests to identify specific cell markers associated with the lymphoma Accurate diagnosis is crucial for determining the best course of action and determining the disease stage.
Treatment Protocols: Treatment for diffuse follicle center lymphoma typically involves multiple approaches, tailored to the patient's stage and overall health, such as: - Chemotherapy to eliminate cancerous cells - Immunotherapy to boost the body's natural defenses - Targeted therapy aimed at specific genetic mutations - Radiation therapy for localized disease - Stem cell transplantation in certain cases Supportive care, including management of symptoms and side effects, also plays an important role, aiming to improve quality of life during and after treatment. Close medical supervision is essential for monitoring response to therapy and managing any complications or relapses.
Clinical Advice & FAQs
Billing Guidance
Is C82.55 a billable ICD-10 code?
Yes, C82.55 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.55?
Clinical documentation must specify the nature of Diffuse follicle center lymphoma, lymph nodes of inguinal region and lower limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
